The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Shock and Awe Nick Mather told us all on the 17th December that this was a nice problem to have not negative The Alpala committee will meet 15th of this month to decide on whether to keep the same or change
To Bigger cheaper to get out strategy That will take longer and the price has dropped thats the shock over
No this will bounce back strongly with AWE if the drill results from TAD 4 5 6 are equally as good as TAD 1
I have been here a while crewtime One of the reasons I bought in was what a genuine person Nick Mather come across as As a cab driver of 35 years you become better and better of judging peoples character by their mannerisms No not many people I know give 1% of their wealth to charity every year Stick with Nick he is far better than most in my opinion